GDMT Optimization Checklist

Guideline-Directed Medical Therapy Assessment for HFrEF

Current LVEF (%)

ACE Inhibitor

ARB

ARNI (Sacubitril/Valsartan)

Beta-Blocker

Aldosterone Antagonist (MRA)

SGLT2 Inhibitor

Hydralazine/Isosorbide Dinitrate

Ivabradine

HR ≥70 bpm on max tolerated beta-blockerIvabradine candidate

Black race/ethnicityH-ISDN consideration per AHA guidelines

CKD (Cr >2.5 or K >5.0)MRA and RAAS inhibitor caution

Current hospitalization for decompensated HFStart/uptitrate when euvolemic

LVEF has improved to >40% on treatmentHFimpEF — do NOT stop GDMT

GDMT Optimization Score —

Status —

Enter medication data above.